Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel Jak kinase inhibitors for use in inflammation and cancer

Sep. 12, 2003

New antitumor, antibacterial and antifungal agents from Penicillium sp.

Sep. 10, 2003

Dual inhibitors of HER1/HER2 presented at ACS meeting by Bristol-Myers Squibb

Sep. 9, 2003

Small molecule selectively targeting HER2 selected for development by Pfizer

Sep. 9, 2003

Valera adopted as new name for Hydro Med Sciences

Sep. 9, 2003

Biphenyl-based antiandrogenic agents covered by Endorecherche patent

Sep. 9, 2003

Novel GnRH modulators prepared and tested by Pfizer researchers

Sep. 9, 2003

GW-572016, a dual EGFR/ErbB-2 TK inhibitor, discussed in ACS presentation

Sep. 8, 2003

Bicyclic androgen receptor antagonists pursued at BMS

Sep. 8, 2003

Japanese group identifies new antiangiogenic/antimetastatic MMP inhibitor

Sep. 8, 2003

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...